IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q4 2025 Holdings

Filed 2026-02-17 | 107 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$69.6M3,314,4083.5%
Natera Inc(NTRA)COM632307104$76.6M334,4933.9%
Abivax SA(ABVX)SPONSORED ADS00370M103$88.7M657,8344.5%
United Therapeutics Corp del(UTHR)COM91307C102$123.1M252,5926.2%
GSK PLC(GSK)SPONSORED ADR37733W204$131.4M2,679,7216.6%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$138.2M225,0007.0%
Vera Therapeutics Inc(VERA)CL A92337R101$155.6M3,072,3047.8%
PreviousPage 3 of 3